EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work



Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work



Bmj 301(6755): 802-804



Cases are reported in 3 patients who developed invasive aspergillosis while receiving immunosuppressive therapy with high dose corticosteroids and cyclophosphamide for systemic vasculitides at the same time as demolition work was occurring on the hospital site. All 3 patients died.

(PDF 0-2 workdays service: $29.90)

Accession: 001869427

Download citation: RISBibTeXText

PMID: 2224271



Related references

Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia. Haematologica 95(6): 996-1003, 2011

Invasive aspergillosis in immunosuppressed patients. Bmj 301(6759): 1046-1047, 1990

Culture yield from immunosuppressed cancer patients with invasive aspergillosis. Clinical Infectious Diseases 31(1): 260, July, 2000

Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients. Mycoses 48 Suppl 1: 12-17, 2005

Typical radiological findings and course of invasive pulmonary aspergillosis in immunosuppressed patients. RoFO, Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuen bildgebenden Verfahren 167(1): 24-31, 1997

Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimicrobial Agents and ChemoTherapy 38(5): 911-917, 1994

Low incidence of invasive aspergillosis in a hospital area under building works. Medicina Clinica 127(15): 595-595, 2006

Invasive aspergillosis in severely immunosuppressed patients: significant progress, but many unresolved problems. Transplant Infectious Disease 10(3): 151-155, 2008

Invasive nosocomial pulmonary aspergillosis risk factors and hospital building works. Epidemiology & Infection 99(2): 407-412, 1987

Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus , or sirolimus. Journal of Infectious Diseases 175(1): 223-225, 1997

Invasive aspergillosis caused by Aspergillus terreus in a non-immunosuppressed patient. Journal of the Association of Physicians of India 50: 1086-1088, 2002

Invasive pulmonary aspergillosis in a non-immunosuppressed patient. Report of a case. Journal de Mycologie Medicale 2(2): 95-98, 1992

A non-immunosuppressed patient with presumably invasive pulmonary aspergillosis and a favourable outcome. Netherlands Journal of Medicine 26(4): 112-119, 1983

Cavitary infiltrate in an immunosuppressed patient. Invasive pulmonary aspergillosis. Indiana Medicine 81(1): 23-24, 1988

Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis. Journal of Infectious Diseases 186(6): 869-871, 2002